Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Hematopoietic Stem Cells”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT06748586
What this trial is testing

The Effect of Hyperbaric Oxygen Therapy on Circulating Hematopoietic Stem Cell Population

Who this might be right for
Circulating Hematopoietic Stem Cells
Assaf-Harofeh Medical Center 60
Not applicableStudy completedNCT04038827
What this trial is testing

Origin of CEC in Patients After Allo-HSCT

Who this might be right for
Graft Versus Host Disease, AcuteEndothelial DysfunctionImmune Tolerance
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 15
Not applicableStudy completedNCT02027467
What this trial is testing

Study to Assess the Effect of StemAlive® Supplement on the Levels of Stem Cells in Human Volunteers

Who this might be right for
Healthy
Vedic Lifesciences Pvt. Ltd. 23
Not applicableStudy completedNCT02064972
What this trial is testing

CEC Count Changes to Support GvHD Diagnosis.

Who this might be right for
Graft vs Host DiseaseComplications of Organ Transplant Stem CellsEndothelial Dysfunction
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 50
Testing effectiveness (Phase 2)Study completedNCT00002663
What this trial is testing

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

Who this might be right for
EBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma
Atara Biotherapeutics 58